The Effectiveness of Cognitive Behavioral Therapy-Based Intervention on Improving Sleep-Related Outcomes for People with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Hongjuan Wang,Rongzhi Li,Lin Ge,Fan Xu,James Wiley,Siyuan Tang,Mei Sun
DOI: https://doi.org/10.2147/prbm.s449577
IF: 3.974
2024-03-10
Psychology Research and Behavior Management
Abstract:Hongjuan Wang, 1 Rongzhi Li, 1 Lin Ge, 2 Fan Xu, 1 James Allen Wiley, 3 Siyuan Tang, 1 Mei Sun 1, 4 1 Xiangya School of Nursing, Central South University, Changsha, Hunan Province, People's Republic of China; 2 Department of Alcohol Addiction and Internet Addiction, Brain Hospital of Hunan Province (The Second People's Hospital of Hunan Province), Changsha, Hunan Province, People's Republic of China; 3 Department of Family and Community Medicine and Institute for Health Policy Research, University of California, San Francisco, CA, USA; 4 School of Nursing, Changsha Medical University, Changsha, Hunan Province, People's Republic of China Correspondence: Siyuan Tang; Mei Sun, Xiangya School of Nursing, Central South University, Changsha, Hunan Province, 410013, People's Republic of China, Email ; Background: Sleep-related outcomes in people with diabetes are poor, which is closely linked to reducing the development of diabetes. Cognitive behavioral therapy (CBT) based intervention presents innovative solutions that can help improve sleep-related outcomes. Aim: This synthesis aims to assess the effectiveness of CBT-based intervention compared to controls in Randomized Controlled Trials (RCTs) for sleep-related outcomes among people with diabetes. Methods: Eight electronic databases were systematically searched: PubMed, EMBASE, Cochrane library, Web of Science, PsycINFO, CINAHL, China National Knowledge Infrastructure (CNKI), and Wan Fang database. We examined CBT-based intervention's effectiveness on sleep-related outcomes in people with diabetes in RCTs identified in these databases from their inception to 1st November 2023, and updated on 15 January 2024. The risk of bias was assessed using the Cochrane Risk of Bias tool by two reviewers. The meta-analysis of included studies was conducted by RevMan 5.3 software. Results: Seven studies in total (n = 2633 participants) were included in this systematic review based on our inclusion criteria. The systematic review found CBT-based intervention significantly improved sleep quality (Pittsburgh Sleep Quality Index, PSQI scores) at immediate post-intervention [95% CI=(− 1.31 to -0.32), p = 0.001], six months [95% CI=(− 0.75 to − 0.22), p = 0.0003], and 12 months [95% CI=(− 0.72 to − 0.24), < 0.0001], compared to control groups. Furthermore, our findings demonstrated that six sessions [95% CI= (− 0.38 to − 0.13), p < 0.0001] or more than six sessions [95% CI=(− 1.76 to − 0.02), p = 0.05] of CBT-based intervention could improve sleep quality compared to controls (I 2 =0%). Interestingly, CBT-based intervention improves total sleep time at post-intervention in people with diabetes compared to the control group [95% CI= (− 0.57 to − 0.12), p = 0.003]. However, there was no significant that CBT-based intervention is beneficial to time to fall asleep [95% CI (− 1.89 to 0.43), p = 0.22] and sleep efficiency [95% CI (− 1.27 to 0.27), p = 0.20] after intervention, compared to control group. Conclusion: CBT-based intervention appears to have a beneficial effect on improving sleep quality and total sleep time among people with diabetes. CBT-based intervention could be considered a strategy among healthcare providers to enhance sleep quality and total sleep time for people with diabetes. More RCTs with rigorous designs and long-term follow-up are warranted to provide conclusive evidence of the CBT-based intervention on sleep-related outcomes and to explore the mechanisms by which the CBT-based interventions improve sleep-related outcomes. Keywords: diabetes, cognitive behavioral therapy, sleep, systematic review, meta-analysis World Health Organization reported that the number of people with diabetes is expected to increase to 642 million worldwide by 2030. 1 According to the Centers for Disease Control and Prevention, an estimated 38.4 million people of all ages, which accounts for approximately 11.6% of the US population, were living with diabetes in 2021. 2 The total estimated direct and indirect costs associated with diagnosed diabetes in the United States in 2022 amounted to a staggering $413 billion. 2 An important but less-known risk factor for the development of diabetes is having a sleep disturbance. 3,4 Sleep disturbance in people with diabetes is a complex symptom that refers to impaired sleep quality and/or abnormal sleep duration. 5 Compared to other populations, people with Type 2 diabetes Mellitus (T2DM) might suffer from sleep disturbances due to diabetes symptoms such as frequency nocturnal urination, hyperglycemia, insulin resistance, which might influence the sleep varia -Abstract Truncated-
psychology, clinical, multidisciplinary